Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Carvajal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revista Medica De Chile|October 1, 1988
[Differences in hematologic variables according to ABO blood group]C Y Valenzuela, T Carvajal, K Marinkovic
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studiesJ Puente, T Carvajal, S Parra, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2J Puente, T Carvajal, S Parra, et al.
Blood Cancer Journal|November 15, 2014
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemiaJ E Castro, M Y Choi, T Carvajal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revista Medica De Chile|October 1, 1988
[Differences in hematologic variables according to ABO blood group]C Y Valenzuela, T Carvajal, K Marinkovic
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studiesJ Puente, T Carvajal, S Parra, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1993
In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2J Puente, T Carvajal, S Parra, et al.
Blood Cancer Journal|November 15, 2014
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemiaJ E Castro, M Y Choi, T Carvajal, et al.
Pageof 1